Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Ascorbic Acid in DMSO for Squamous Cell Carcinoma
NCT05932511Phase 1Unknown
- Sponsor
- Center for Biomedical Research
- Start
- Jun 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ascorbic acid in Squamous cell carcinoma (SCC) (2 arms), sponsored by Center for Biomedical Research. Primary endpoint: Lesion Resolution at 8 weeks. Status: unknown.
02
Drugs
ascorbic acid
03
Conditions
Squamous cell carcinoma (SCC)
Beyond the preview
Go deeper on NCT05932511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05932511.